erythromycin has been researched along with moxalactam in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (53.85) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Grime, K; Paine, SW | 1 |
Noel, GJ; Teele, DW | 1 |
Liu, S; Meyer, RD | 1 |
Fond, G; Godard, J; Mahul, P; Motin, J; Perrot, D; Reverdy, ME | 1 |
Gaspar, MC; Ponte, MC; Soriano, F | 1 |
Hara, K; Kanda, T; Saito, A; Sawatari, K; Toro, J | 1 |
Goldner, M; Scudamore, RA | 1 |
Coudron, PE; Dalton, HP; Ford, JM | 1 |
Aoki, M; Kunii, O; Miyashita, H; Miyashita, T; Nishiya, H; Ohyatsu, I; Ono, Y; Sekino, N; Sugiyama, H; Tokumura, Y | 1 |
Carroll, S; Goonetilleke, A; Hargreaves, M | 1 |
1 review(s) available for erythromycin and moxalactam
Article | Year |
---|---|
[Two cases of Campylobacter fetus subsp. fetus sepsis].
Topics: Bacteremia; Campylobacter fetus; Campylobacter Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Moxalactam | 1994 |
12 other study(ies) available for erythromycin and moxalactam
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefotaxime; Drug Combinations; Drug Synergism; Erythromycin; Gentamicins; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Moxalactam; Penicillin G; Rifampin; Sulfamethoxazole; Tetracycline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1987 |
[Erythromycin and latamoxef in the initial treatment of diffuse peritonitis with visceral failure].
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Moxalactam; Multiple Organ Failure; Peritonitis | 1987 |
The in vitro responses of Bacteroides fragilis to Moxalactam, Cefotaxime, Cefmetazole, Josamycin and erythromycin.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefmetazole; Cefotaxime; Cephamycins; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Moxalactam | 1982 |
New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
Topics: Animals; Cefotaxime; Cefotiam; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Legionnaires' Disease; Moxalactam | 1983 |
Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cell Membrane Permeability; Cephamycins; Edetic Acid; Erythromycin; Gentamicins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1982 |
Tetrazolium reduction as an aid for streptococcal growth detection with agar dilution susceptibility testing.
Topics: Agar; Ampicillin; Chloramphenicol; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillin G; Piperacillin; Streptococcus; Tetrazolium Salts | 1983 |
Sourcing faecal pollution from onsite wastewater treatment systems in surface waters using antibiotic resistance analysis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cephalothin; Chlortetracycline; Colony Count, Microbial; Discriminant Analysis; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Feces; Gentamicins; Humans; Moxalactam; Ofloxacin; Tetracycline; Water Microbiology; Water Pollution | 2005 |